Cancer statistics, 2019
Cancer statistics, 2019
复制标题
DOI：
10.3322/caac.21551
复制
发表时间：
2019-01-01
影响因子：
254.7
通讯作者：
Jemal, Ahmedin
中科院分区：
文献类型：
--
作者：
Siegel, Rebecca L.;Miller, Kimberly D.;Jemal, Ahmedin
每年，美国癌症协会估计美国将发生的新癌症病例和死亡人数，并汇编有关癌症发病率，死亡率和生存率的最新数据。截至2015年的发病率数据由监测，流行病学和最终结果计划;国家癌症登记计划;和北美中央癌症登记协会收集。截至2016年的死亡率数据由国家卫生统计中心收集。2019年，预计美国将发生1，762，450例新发癌症病例和606，880例癌症死亡。在过去十年的数据中，女性的癌症发病率（2006-2015年）保持稳定，男性每年下降约2%，而癌症死亡率（2007-2016年）每年分别下降1.4%和1.8%。总体癌症死亡率从1991年到2016年持续下降了27%，这意味着如果死亡率保持在峰值，癌症死亡人数将减少约2，629，200人。虽然癌症死亡率的种族差距正在慢慢缩小，但社会经济不平等正在扩大，最明显的差距是最可预防的癌症。例如，与最富裕的县相比，2012-2016年期间，最贫困县的宫颈癌死亡率高出2倍，男性肺癌和肝癌死亡率高出40%。一些州同时拥有最富裕和最贫穷的县，这表明有机会更公平地传播有效的癌症预防，早期发现和治疗策略。以弱势群体为重点，更广泛地应用现有的癌症控制知识，无疑将加快防治癌症的进展。
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2015, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2016, were collected by the National Center for Health Statistics. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2006-2015) was stable in women and declined by approximately 2% per year in men, whereas the cancer death rate (2007-2016) declined annually by 1.4% and 1.8%, respectively. The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the racial gap in cancer mortality is slowly narrowing, socioeconomic inequalities are widening, with the most notable gaps for the most preventable cancers. For example, compared with the most affluent counties, mortality rates in the poorest counties were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers during 2012-2016. Some states are home to both the wealthiest and the poorest counties, suggesting the opportunity for more equitable dissemination of effective cancer prevention, early detection, and treatment strategies. A broader application of existing cancer control knowledge with an emphasis on disadvantaged groups would undoubtedly accelerate progress against cancer.